Aromatase inhibitors showed no clear difference in miscarriage rate per couple compared with anti‐oestrogens (low certainty).
Aromatase inhibitors showed no clear difference in ectopic pregnancy rate per couple compared with anti‐oestrogens (low certainty).
Aromatase inhibitors may leads to lower live birth rate per couple compared with gonadotropins (low certainty).
It is very uncertain whether aromatase inhibitors changes multiple pregnancy rate per couple compared with gonadotropins (very low certainty).
Aromatase inhibitors may leads to lower clinical pregnancy rate per couple compared with gonadotropins (low certainty).
Aromatase inhibitors may leads to lower miscarriage rate per couple compared with gonadotropins (low certainty).
Aromatase inhibitors showed no clear difference in OHSS rate per couple compared with gonadotropins (low certainty).
Aromatase inhibitors showed no clear difference in ectopic pregnancy per couple compared with gonadotropins (low certainty).
Aromatase inhibitors showed no clear difference in live birth rate per couple compared with anti‐oestrogens (low certainty).
Aromatase inhibitors showed no clear difference in multiple pregnancy rate per couple compared with anti‐oestrogens (low certainty).
Aromatase inhibitors showed no clear difference in clinical pregnancy rate per couple compared with anti‐oestrogens (low certainty).
Aromatase inhibitors leads to lower overall breast cancer incidence compared with placebo (high certainty).
Aromatase inhibitors leads to higher severe toxicity compared with placebo (high certainty).
Aromatase inhibitors may leads to lower overall breast cancer incidence compared with tamoxifen (indirect comparison)a (low certainty).
It is very uncertain whether exercise therapies changes adherence to aromatase inhibitors compared with standard care (very low certainty).
It is very uncertain whether aromatase inhibitors with gonadotropins changes live birth rate per couple compared with anti‐oestrogens with gonadotropins (very low certainty).
Aromatase inhibitors with gonadotropins showed no clear difference in multiple pregnancy rate per couple compared with anti‐oestrogens with gonadotropins (low certainty).
It is very uncertain whether aromatase inhibitors with gonadotropins changes clinical pregnancy rate per couple compared with anti‐oestrogens with gonadotropins (very low certainty).
It is very uncertain whether aromatase inhibitors with gonadotropins changes miscarriage rate per couple compared with anti‐oestrogens with gonadotropins (very low certainty).